Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. IBRX
    4. >
  4. Valuation

Valuation

-
stocks logo
IBRX
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

Is IBRX Overvalued？

IBRX is now in the zone, suggesting that IBRX current forward PE ratio of -4.35 is considered compare with the five-year average of -8.13.
P/E
EV/EBITDA
P/S
P/B
P/E
bubble
P/E

IBRX Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
IBRX.O
Immunitybio Inc
loss
Average P/E: 98.15
35.77%
2.08B
stocks logo
MIRM.O
Mirum Pharmaceuticals Inc
loss
Average P/E: 98.15
35.39%
2.25B
stocks logo
LGND.O
Ligand Pharmaceuticals Inc
32.27
Average P/E: 98.15
-273.88%
2.16B
stocks logo
NAMS.O
NewAmsterdam Pharma Company NV
loss
Average P/E: 98.15
2.23B
stocks logo
VCEL.O
Vericel Corp
164.04
Average P/E: 98.15
19.72%
2.47B
stocks logo
MTSR.O
Metsera Inc
loss
Average P/E: 98.15
0.00

IBRX Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

IBRX FAQs

Is IBRX currently overvalued based on its P/E ratio?

According to the provided data, IBRX's 5-year historical average forward P/E ratio is -8.13. IBRX forward P/E ratio is -4.35, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for IBRX?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has IBRX's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 3053.34 to 345.67, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for IBRX's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

IBRX PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PE
-8.13
Current PE
-4.35
Overvalued PE
-0.53
Undervalued PE
-15.74

IBRX EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average EV
0.00
Current EV
0.00
Overvalued EV
0.00
Undervalued EV
0.00

IBRX P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
5Y Average PS
11044.92
Current PS
24.02
Overvalued PS
29526.17
Undervalued PS
-7436.33

IBRX Competitors Valuation Multiple

P/E
EV/EBITDA
P/S
P/E

P/E Multiple

Earnings Growth
Market Cap
stocks logo
IBRX.O
Immunitybio Inc
loss
Average P/E: 98.15
35.77%
2.08B
stocks logo
MIRM.O
Mirum Pharmaceuticals Inc
loss
Average P/E: 98.15
35.39%
2.25B
stocks logo
LGND.O
Ligand Pharmaceuticals Inc
32.27
Average P/E: 98.15
-273.88%
2.16B
stocks logo
NAMS.O
NewAmsterdam Pharma Company NV
loss
Average P/E: 98.15
2.23B
stocks logo
VCEL.O
Vericel Corp
164.04
Average P/E: 98.15
19.72%
2.47B
stocks logo
MTSR.O
Metsera Inc
loss
Average P/E: 98.15
0.00

IBRX Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is IBRX undervalued？Is IBRX overvalued compared to its competitors？

IBRX FAQs

Is IBRX currently overvalued based on its P/E ratio?

According to the provided data, IBRX's 5-year historical average forward P/E ratio is -8.13. IBRX forward P/E ratio is -4.35, which is categorized as Fair.

What is the significance of the EV/EBITDA ratio for IBRX?

The EV/EBITDA ratio helps assess the company's valuation relative to its earnings before interest, taxes, depreciation, and amortization, providing a clearer picture of its operating performance.

How has IBRX's Price to Sales (PS) ratio evolved?

The PS ratio decreased from 3053.34 to 345.67, reflecting changes in the company's revenue relative to its market capitalization.

What are the key indicators to watch for IBRX's financial performance?

Key indicators include valuation ratios (P/E, EV/EBITDA, P/FCF), revenue growth, and profitability metrics to assess overall financial health.

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is IBRX undervalued？Is IBRX overvalued compared to its competitors？
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free